Who
Lou Basenese
Director
Company insider
Files Form 4 as: Director, ClearSign Technologies; Director, ENDRA Life Sciences.
In numbers
- Trades disclosed
- 27
- Buys
- 5
- Sells
- 2
- Bought
- $42K
- Sold
- $92K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 9 Apr 2020
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —3,766 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,595 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,595 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —3,024 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —3,024 at $0.00 | filing |
| 21 Jan 2026filed 23 Jan 2026 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —60,324 at $0.00 | filing |
| 21 Jan 2026filed 23 Jan 2026 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —60,324 at $0.00 | filing |
| 1 Oct 2025filed 3 Oct 2025 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —24,621 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —34,722 at $0.00 | filing |
| 11 Jun 2025filed 1 Jul 2025 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —5,384 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | CLIR ClearSign Technologiesoption or derivative · Life-science tools | SEC FORM 4 Code A | —10,923 at $0.00 | filing |
| 2 Jan 2024filed 23 Feb 2024 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —600 at $0.00 | filing |
| 30 Jan 2023filed 1 Feb 2023 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —6,746 at $0.00 | filing |
| 28 Mar 2022filed 30 Mar 2022 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —74,500 at $0.00 | filing |
| 3 Jan 2022filed 4 Jan 2022 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 26 Aug 2021filed 27 Aug 2021 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Sold | $9,2505,000 at $1.85 | filing |
| 25 Aug 2021filed 27 Aug 2021 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Sold | $82K45,000 at $1.83 | filing |
| 5 Apr 2021filed 7 Apr 2021 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 4 Jan 2021filed 25 Mar 2021 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 22 Oct 2020filed 26 Oct 2020 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.